Joseph Blecha, MS, has spent 18 years at UCSF advancing radiochemistry to improve imaging and treatment of diseases like Alzheimer’s, ALS, and prostate cancer. Inspired during his early chemistry studies, he transitioned from organic chemistry to radiochemistry, now producing short-lived isotopes with UCSF’s cyclotron group.